K-numberK241322
Device nameElectric Breast Pump (LD-208L, LD-3010L, LD-2010L, LD-3010, LD-2010)
ApplicantJoytech Healthcare Co. , Ltd.
Product codeHGX
Device classClass II
Decision dateDec 19, 2024
DecisionSubstantially Equivalent
Regulation884.5160
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Electric Breast Pump (models LD-208L, LD-3010L, LD-2010L, LD-3010, LD-2010) is an electrically powered device used by lactating women to express and collect breast milk. It can operate in single or double pumping mode and features multiple operational modes including stimulation, expression, bionic sucking, and variable frequency modes, with adjustable suction levels and cycle speeds.

Technological characteristics

The subject device differs from the predicate (YM-8166) in power supply options (USB charging and alkaline batteries versus DC 5V), vacuum pressure ranges (50-290 mmHg expression vs. 85-280 mmHg), cycle speeds (20-65 cpm expression vs. 24-84 cpm), available modes (4 modes vs. 5 modes), and overall suction level specifications. Both devices use microcontroller-based cycling, 2-phase expression patterns, and backflow protection via silicone diaphragm mechanisms.

Test standards cited

IEC 60601-1 Edition 3.2 (medical electrical equipment safety), IEC 62133-2:2017 (lithium battery safety), IEC 60086-5:2016 (primary battery safety), IEC 60601-1-11 Edition 3.1 (home healthcare electrical equipment), IEC 60601-1-2:2014+A1:2020 (electromagnetic compatibility), and ISO 10993 standards (ISO 10993-5:2009 cytotoxicity, ISO 10993-10:2021 skin sensitization, ISO 10993-23:2021 skin irritation).

Substantial equivalence argument

Although the subject device has different vacuum pressures, cycle speeds, operating modes, and power supply configurations than the predicate, these technological differences do not raise different questions of safety and effectiveness because both devices share the same intended use (expressing and collecting breast milk from lactating women), same regulatory classification (Class II), same product code (HGX), and fundamentally similar design architecture including microcontroller cycling control, 2-phase expression patterns, and backflow protection. Performance testing demonstrated the subject device meets its design specifications and maintains safety across all modes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →